BALERNA, Switzerland--(BUSINESS WIRE)-- APR Applied Pharma Research s.a. ("APR"), the Swiss, independent developer of science-driven, patent-protected healthcare products, communicates that new clinical data on the role of Nexodyn, an ... Yahoo! UK and Ireland, 1 week ago
Nexodyn latest clinical outcomes on the healing of Diabetic Foot (DF) post-surgical lesions have been presented at the 7th International Symposium on the Diabetic Foot (SDF), The Hague, The Netherlands (20-23 May 2015) - EON: Enhanced Online News, 15 hours ago
APR Applied Pharma Research S.A. ("APR") Today Announced That HBM Partners AG ("HBM") Has Acquired a Minority Stake in APR
HBM Partners AG Invests in APR Applied Pharma Research SA BALERNA, Switzerland & ZUG, Switzerland--(BUSINESS WIRE)-- HBM Partners AG ( HBM ), one of the leading Swiss Private Equity Investors and global leader in healthcare-focused ...CNBC, 2 months ago APR Applied Pharma Research S.A. Today Announced That Has Acquired A Minority Stake In BioSpace, 2 months ago
on your WebpageAdd Widget >Get your members hooked!